{"transactions":[{"id":733649,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-17T20:05:21.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":9450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest in 12 equal monthly installments beginning on July 17, 2026, provided that the shares subject to the option will vest in full on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual meeting of stockholders."}],"balance_after":9450,"derivative":{"exercise_price":0,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":9450},"source":{"system":"sec-edgar","filing":"0001193125-26-274128","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000119312526274128/ownership.xml","form_type":"4"}},{"id":733648,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-17T20:05:21.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":28700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 17, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":134899,"source":{"system":"sec-edgar","filing":"0001193125-26-274128","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000119312526274128/ownership.xml","form_type":"4"}},{"id":742898,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T20:30:06.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and be fully exercisable on the earlier of (i) the date of the issuer's 2027 annual stockholders meeting or (ii) June 8, 2027, subject to the reporting person's continued service to the issuer on the vesting date."}],"balance_after":18000,"derivative":{"exercise_price":23.58,"expiration_date":"2036-06-07","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001214133-26-000002","document":"form4-06102026_080600.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000121413326000002/form4-06102026_080600.xml","form_type":"4"}},{"id":751238,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-03T23:08:32.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":10833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest in 4 equal quarterly installments beginning on June 1, 2026."}],"balance_after":106199,"source":{"system":"sec-edgar","filing":"0001193125-26-255990","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000119312526255990/ownership.xml","form_type":"4"}},{"id":1032905,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-24T20:18:31.000Z","date":"2025-09-22","kind":"grant","planned":false,"acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest as to 1/9 of the total award monthly with the first tranche vesting on October 1, 2025, subject to the reporting person's continued service to the Issuer on the applicable vesting date."}],"balance_after":18000,"derivative":{"exercise_price":23.67,"expiration_date":"2035-09-21","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001214133-25-000007","document":"form4-09242025_080927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000121413325000007/form4-09242025_080927.xml","form_type":"4"}},{"id":1039139,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-16T20:26:27.000Z","date":"2025-09-15","kind":"sale","planned":false,"acquired":false,"shares":20744,"price":22.3696,"value":464034.9824,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.14 to $22.585, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001214133-25-000005","document":"form4-09162025_080924.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000121413325000005/form4-09162025_080924.xml","form_type":"4"}},{"id":1113049,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-12T22:05:07.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":9450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest in 12 equal monthly installments beginning on July 11, 2025, provided that the shares subject to the option will vest in full on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual meeting of stockholders."}],"balance_after":9450,"derivative":{"exercise_price":1.63,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":9450},"source":{"system":"sec-edgar","filing":"0000950170-25-085617","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000095017025085617/ownership.xml","form_type":"4"}},{"id":1113048,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T22:05:07.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":28700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 11, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":95366,"source":{"system":"sec-edgar","filing":"0000950170-25-085617","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000095017025085617/ownership.xml","form_type":"4"}},{"id":1160892,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-02T22:00:09.000Z","date":"2025-05-02","kind":"grant","planned":false,"acquired":true,"shares":15833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest in 4 equal quarterly installments beginning on June 1, 2025."}],"balance_after":66666,"source":{"system":"sec-edgar","filing":"0000950170-25-062995","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000095017025062995/ownership.xml","form_type":"4"}},{"id":1388044,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-10T20:05:06.000Z","date":"2024-08-02","kind":"grant","planned":false,"acquired":true,"shares":15833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest in 4 equal quarterly installments beginning on September 1, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reported amounts in Column 5 of Table I reflect the Reporting Person's beneficial ownership as of the date of filing this Form 4."}],"balance_after":50833,"source":{"system":"sec-edgar","filing":"0000950170-24-114050","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000095017024114050/ownership.xml","form_type":"4"}},{"id":1421281,"issuer":{"id":76268,"kind":"organization","name":"Chrome Holding Co.","symbol":"MEHCQ"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-08-28T16:34:07.000Z","date":"2024-08-26","kind":"grant","planned":false,"acquired":true,"shares":658485,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\") issued pursuant to the 23andMe Holding Co. Amended and Restated Outside Director Compensation Policy effective as of September 6, 2023, all of which vest on the earlier of (a) the first anniversary of the grant date and (b) the date of the issuer's 2025 annual meeting of stockholders. Each RSU represents the contingent right to receive one share of Class A common stock of the issuer."}],"balance_after":895961,"source":{"system":"sec-edgar","filing":"0001628280-24-038683","document":"wk-form4_1724877237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804591/000162828024038683/wk-form4_1724877237.xml","form_type":"4"}},{"id":1424099,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-23T20:05:04.000Z","date":"2024-08-22","kind":"sale","planned":false,"acquired":false,"shares":44250,"price":5.1613,"value":228387.525,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.045 to $5.230. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request."}],"balance_after":35000,"source":{"system":"sec-edgar","filing":"0000950170-24-100168","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000095017024100168/ownership.xml","form_type":"4"}},{"id":1481824,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-12T20:46:06.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 12, 2025 or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":79250,"source":{"system":"sec-edgar","filing":"0000950170-24-072515","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000095017024072515/ownership.xml","form_type":"4"}},{"id":1642779,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-14T22:58:22.000Z","date":"2023-07-15","kind":"grant","planned":false,"acquired":true,"shares":8541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest as to 50% of the shares on September 1, 2023, as to 25% of the shares on December 1, 2023, and as to the remaining shares on March 1, 2024, provided the Reporting Person continues to serve as a consultant under the terms of the consulting agreement between the Reporting Person and the Issuer."}],"balance_after":44250,"source":{"system":"sec-edgar","filing":"0000950170-24-015412","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000095017024015412/ownership.xml","form_type":"4"}},{"id":1785259,"issuer":{"id":76268,"kind":"organization","name":"Chrome Holding Co.","symbol":"MEHCQ"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-09-08T16:57:09.000Z","date":"2023-09-06","kind":"grant","planned":false,"acquired":true,"shares":165088,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\") issued pursuant to the 23andMe Holding Co. Amended and Restated Outside Director Compensation Policy (the \"Director Compensation Policy\"), all of which vest on the earlier of (a) the first anniversary of the grant date and (b) the date of the issuer's 2024 annual meeting of stockholders. Each RSU represents the contingent right to receive one share of Class A common stock of the issuer."}],"balance_after":237476,"source":{"system":"sec-edgar","filing":"0001209191-23-048806","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804591/000120919123048806/doc4.xml","form_type":"4"}},{"id":1811825,"issuer":{"id":110693,"kind":"organization","name":"DICE Therapeutics, Inc.","symbol":"DICE"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-08-09T20:29:13.000Z","date":"2023-08-09","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":31250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each Option to purchase shares of Common Stock that was outstanding but not vested as of immediately prior to the Closing (the \"Unvested Option\"), became fully vested and exercisable (the \"Vested Option\").  Each Vested Option was automatically cancelled and converted into the right to receive an amount in cash, without interest, less any applicable tax withholding, equal to the product obtained by multiplying (i) the excess, if any, of the Offer Price over the exercise price per share of Common Stock underlying such Option by (ii) the number of shares of Common Stock underlying such Option. Except if the exercise price per share of Common Stock of the Option was equal to or greater than the Offer Price, such Option was cancelled without any cash payment or other consideration being made in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Company's Stock Option (the \"Option\") is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":14.98,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":31250},"source":{"system":"sec-edgar","filing":"0001209191-23-045175","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919123045175/doc4.xml","form_type":"4"}},{"id":1811824,"issuer":{"id":110693,"kind":"organization","name":"DICE Therapeutics, Inc.","symbol":"DICE"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-08-09T20:29:13.000Z","date":"2023-08-09","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each Option to purchase shares of Common Stock that was outstanding but not vested as of immediately prior to the Closing (the \"Unvested Option\"), became fully vested and exercisable (the \"Vested Option\").  Each Vested Option was automatically cancelled and converted into the right to receive an amount in cash, without interest, less any applicable tax withholding, equal to the product obtained by multiplying (i) the excess, if any, of the Offer Price over the exercise price per share of Common Stock underlying such Option by (ii) the number of shares of Common Stock underlying such Option. Except if the exercise price per share of Common Stock of the Option was equal to or greater than the Offer Price, such Option was cancelled without any cash payment or other consideration being made in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Option vests as to 1/48th of the total shares monthly, beginning August 20, 2021, subject to the Reporting Holder's continued service to the Registrant."}],"balance_after":0,"derivative":{"exercise_price":17,"expiration_date":"2031-09-14","underlying":"Common Stock","underlying_shares":22600},"source":{"system":"sec-edgar","filing":"0001209191-23-045175","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919123045175/doc4.xml","form_type":"4"}},{"id":1811823,"issuer":{"id":110693,"kind":"organization","name":"DICE Therapeutics, Inc.","symbol":"DICE"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-08-09T20:29:13.000Z","date":"2023-08-09","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8261,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each Option to purchase shares of Common Stock that was outstanding but not vested as of immediately prior to the Closing (the \"Unvested Option\"), became fully vested and exercisable (the \"Vested Option\").  Each Vested Option was automatically cancelled and converted into the right to receive an amount in cash, without interest, less any applicable tax withholding, equal to the product obtained by multiplying (i) the excess, if any, of the Offer Price over the exercise price per share of Common Stock underlying such Option by (ii) the number of shares of Common Stock underlying such Option. Except if the exercise price per share of Common Stock of the Option was equal to or greater than the Offer Price, such Option was cancelled without any cash payment or other consideration being made in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Option vests as to 1/36th of the total shares monthly, beginning January 1, 2021, subject to the Reporting Holder's continued service to the Registrant."}],"balance_after":0,"derivative":{"exercise_price":17,"expiration_date":"2031-09-14","underlying":"Common Stock","underlying_shares":8261},"source":{"system":"sec-edgar","filing":"0001209191-23-045175","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919123045175/doc4.xml","form_type":"4"}},{"id":1811822,"issuer":{"id":110693,"kind":"organization","name":"DICE Therapeutics, Inc.","symbol":"DICE"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-08-09T20:29:13.000Z","date":"2023-08-09","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":9138,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each Option to purchase shares of Common Stock that was outstanding but not vested as of immediately prior to the Closing (the \"Unvested Option\"), became fully vested and exercisable (the \"Vested Option\").  Each Vested Option was automatically cancelled and converted into the right to receive an amount in cash, without interest, less any applicable tax withholding, equal to the product obtained by multiplying (i) the excess, if any, of the Offer Price over the exercise price per share of Common Stock underlying such Option by (ii) the number of shares of Common Stock underlying such Option. Except if the exercise price per share of Common Stock of the Option was equal to or greater than the Offer Price, such Option was cancelled without any cash payment or other consideration being made in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Company's Stock Option (the \"Option\") is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":17,"expiration_date":"2031-09-14","underlying":"Common Stock","underlying_shares":9138},"source":{"system":"sec-edgar","filing":"0001209191-23-045175","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919123045175/doc4.xml","form_type":"4"}},{"id":1811821,"issuer":{"id":110693,"kind":"organization","name":"DICE Therapeutics, Inc.","symbol":"DICE"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-08-09T20:29:13.000Z","date":"2023-08-09","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4357,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each Option to purchase shares of Common Stock that was outstanding but not vested as of immediately prior to the Closing (the \"Unvested Option\"), became fully vested and exercisable (the \"Vested Option\").  Each Vested Option was automatically cancelled and converted into the right to receive an amount in cash, without interest, less any applicable tax withholding, equal to the product obtained by multiplying (i) the excess, if any, of the Offer Price over the exercise price per share of Common Stock underlying such Option by (ii) the number of shares of Common Stock underlying such Option. Except if the exercise price per share of Common Stock of the Option was equal to or greater than the Offer Price, such Option was cancelled without any cash payment or other consideration being made in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Company's Stock Option (the \"Option\") is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":17,"expiration_date":"2031-09-14","underlying":"Common Stock","underlying_shares":4357},"source":{"system":"sec-edgar","filing":"0001209191-23-045175","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919123045175/doc4.xml","form_type":"4"}},{"id":1811820,"issuer":{"id":110693,"kind":"organization","name":"DICE Therapeutics, Inc.","symbol":"DICE"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-09T20:29:13.000Z","date":"2023-08-09","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8427,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 18, 2023, DICE Therapeutics, Inc., a Delaware corporation (the \"Issuer\" or the \"Company\") entered into the Agreement and Plan of Merger (the \"Merger Agreement\"), with Eli Lilly and Company, an Indiana corporation (the \"Parent\"), and Durning Acquisition Corporation, a Delaware corporation and a direct or indirect wholly owned subsidiary of the Parent (the \"Merger Sub\"). Pursuant to the Merger Agreement, the Merger Sub merged with and into the Company (such merger and the other transactions contemplated by the Merger Agreement, the \"Merger\") with the Company surviving the Merger as a wholly owned subsidiary of the Parent."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) Upon the closing (the \"Closing\") of the Merger on August 9, 2023, each share of the Company's Common Stock, par value $0.0001 per share (\"Common Stock\"), was either (x) purchased for $48.00 per share (the \"Offer Price\"), without interest, less any applicable withholding taxes or (y) automatically converted into the right to receive an amount in cash without interest, equal to the Offer Price, less any applicable withholding taxes. Immediately prior to the Closing, any repurchase rights of the Company or other similar restrictions on the Common Stock fully lapsed and all Common Stock became fully vested."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-045175","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919123045175/doc4.xml","form_type":"4"}},{"id":1854049,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-06-15T20:02:19.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":12360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest in 12 equal monthly installments beginning on July 14, 2023, provided that the shares subject to the option will vest in full on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual meeting of stockholders."}],"balance_after":12360,"derivative":{"exercise_price":7.71,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":12360},"source":{"system":"sec-edgar","filing":"0000950170-23-028270","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000095017023028270/ownership.xml","form_type":"4"}},{"id":1854048,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-15T20:02:19.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":26250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 14, 2024 or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":35709,"source":{"system":"sec-edgar","filing":"0000950170-23-028270","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000095017023028270/ownership.xml","form_type":"4"}},{"id":1899320,"issuer":{"id":110693,"kind":"organization","name":"DICE Therapeutics, Inc.","symbol":"DICE"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-09T22:02:21.000Z","date":"2023-05-05","kind":"sale","planned":false,"acquired":false,"shares":84097,"price":38.5056,"value":3238205.4432,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.50 to $38.61 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote."}],"balance_after":8427,"source":{"system":"sec-edgar","filing":"0001209191-23-028355","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919123028355/doc4.xml","form_type":"4"}},{"id":2003684,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-02-22T01:21:54.000Z","date":"2023-02-16","kind":"exercise","acquired":false,"shares":3196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest with respect to 1/8th of the underlying shares on May 16, 2022; thereafter, 1/8th of the underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on February 16, 2024, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest with respect to 1/8th of the underlying shares on May 16, 2022; thereafter, 1/8th of the underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on February 16, 2024, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date."}],"balance_after":12783,"derivative":{"underlying":"Common Stock","underlying_shares":3196},"source":{"system":"sec-edgar","filing":"0001209191-23-011457","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000120919123011457/doc4.xml","form_type":"4"}},{"id":2003683,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-22T01:21:54.000Z","date":"2023-02-16","kind":"tax_withholding","acquired":false,"shares":1304,"price":12.64,"value":16482.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 3,196 shares of Common Stock underlying the Reporting Person's RSUs."}],"balance_after":53822,"source":{"system":"sec-edgar","filing":"0001209191-23-011457","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000120919123011457/doc4.xml","form_type":"4"}},{"id":2003682,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-22T01:21:54.000Z","date":"2023-02-16","kind":"exercise","acquired":true,"shares":3196,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":55126,"source":{"system":"sec-edgar","filing":"0001209191-23-011457","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000120919123011457/doc4.xml","form_type":"4"}},{"id":2110392,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-11-18T23:38:19.000Z","date":"2022-11-16","kind":"exercise","acquired":false,"shares":3196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest with respect to 1/8th of the underlying shares on May 16, 2022; thereafter, 1/8th of the underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on February 16, 2024, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest with respect to 1/8th of the underlying shares on May 16, 2022; thereafter, 1/8th of the underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on February 16, 2024, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date."}],"balance_after":15979,"derivative":{"underlying":"Common Stock","underlying_shares":3196},"source":{"system":"sec-edgar","filing":"0001209191-22-057983","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000120919122057983/doc4.xml","form_type":"4"}},{"id":2110391,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-18T23:38:19.000Z","date":"2022-11-16","kind":"tax_withholding","acquired":false,"shares":1106,"price":9.64,"value":10661.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 3,196 shares of Common Stock underlying the Reporting Person's RSUs."}],"balance_after":51930,"source":{"system":"sec-edgar","filing":"0001209191-22-057983","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000120919122057983/doc4.xml","form_type":"4"}},{"id":2110390,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-18T23:38:19.000Z","date":"2022-11-16","kind":"exercise","acquired":true,"shares":3196,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":53036,"source":{"system":"sec-edgar","filing":"0001209191-22-057983","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000120919122057983/doc4.xml","form_type":"4"}},{"id":2119147,"issuer":{"id":76268,"kind":"organization","name":"Chrome Holding Co.","symbol":"MEHCQ"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-11-14T16:38:07.000Z","date":"2022-11-11","kind":"sale","acquired":false,"shares":18421,"price":3.24,"value":59684.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $3.12 to $3.42. Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":72388,"source":{"system":"sec-edgar","filing":"0001209191-22-056631","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804591/000120919122056631/doc4.xml","form_type":"4"}},{"id":2163627,"issuer":{"id":76268,"kind":"organization","name":"Chrome Holding Co.","symbol":"MEHCQ"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-09-08T16:47:33.000Z","date":"2022-09-06","kind":"grant","acquired":true,"shares":14633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units, or RSUs, issued pursuant to the 23andMe Holding Co. Amended and Restated Outside Director Compensation Policy, all of which vest on the earlier of (a) the first anniversary of the grant date or (b) the date of the issuer's 2023 annual meeting of stockholders. Each RSU represents the contingent right to receive one share of Class A common stock of the issuer."}],"balance_after":90809,"source":{"system":"sec-edgar","filing":"0001209191-22-049184","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804591/000120919122049184/doc4.xml","form_type":"4"}},{"id":2172398,"issuer":{"id":76268,"kind":"organization","name":"Chrome Holding Co.","symbol":"MEHCQ"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-08-29T16:29:26.000Z","date":"2022-08-25","kind":"grant","acquired":true,"shares":57755,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units, or RSUs, issued pursuant to the 23andMe Holding Co. Amended and Restated Outside Director Compensation Policy, all of which vest on the earlier of (a) the first anniversary of the grant date or (b) the date of the issuer's 2023 annual meeting of stockholders. Each RSU represents the contingent right to receive one share of Class A common stock of the issuer."}],"balance_after":76176,"source":{"system":"sec-edgar","filing":"0001209191-22-047864","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804591/000120919122047864/doc4.xml","form_type":"4"}},{"id":2179614,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-08-18T22:35:03.000Z","date":"2022-08-16","kind":"exercise","acquired":false,"shares":3196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest with respect to 1/8th of the underlying shares on May 16, 2022; thereafter, 1/8th of the underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on February 16, 2024, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest with respect to 1/8th of the underlying shares on May 16, 2022; thereafter, 1/8th of the underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on February 16, 2024, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date."}],"balance_after":19175,"derivative":{"underlying":"Common Stock","underlying_shares":3196},"source":{"system":"sec-edgar","filing":"0001209191-22-046733","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000120919122046733/doc4.xml","form_type":"4"}},{"id":2179613,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-18T22:35:03.000Z","date":"2022-08-16","kind":"tax_withholding","acquired":false,"shares":1101,"price":11.08,"value":12199.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 3,196 shares of Common Stock underlying the Reporting Person's RSUs."}],"balance_after":49840,"source":{"system":"sec-edgar","filing":"0001209191-22-046733","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000120919122046733/doc4.xml","form_type":"4"}},{"id":2179612,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-18T22:35:03.000Z","date":"2022-08-16","kind":"exercise","acquired":true,"shares":3196,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":50941,"source":{"system":"sec-edgar","filing":"0001209191-22-046733","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000120919122046733/doc4.xml","form_type":"4"}},{"id":2222116,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-24T20:36:40.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":104921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3rd of the shares underlying the option will vest on June 22, 2023; thereafter, 1/3rd of the remaining underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on the June 22, 2025, subject to the optionee's continued service on the Board of Directors of the Company."}],"balance_after":104921,"derivative":{"exercise_price":8.45,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":104921},"source":{"system":"sec-edgar","filing":"0001209191-22-039265","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000120919122039265/doc4.xml","form_type":"4"}},{"id":2225140,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-22T00:06:03.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":18918,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest in 12 equal monthly installments beginning on July 16, 2022, or if earlier, the date of the Issuer's next annual meeting of stockholders."}],"balance_after":18918,"derivative":{"exercise_price":8.07,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":18918},"source":{"system":"sec-edgar","filing":"0001209191-22-038571","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919122038571/doc4.xml","form_type":"4"}},{"id":2225139,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-22T00:06:03.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":9459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 16, 2023 or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":9459,"source":{"system":"sec-edgar","filing":"0001209191-22-038571","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919122038571/doc4.xml","form_type":"4"}},{"id":2238850,"issuer":{"id":110693,"kind":"organization","name":"DICE Therapeutics, Inc.","symbol":"DICE"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2022-06-08T20:48:37.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier to occur of: (i) the one-year anniversary of the grant date and (ii) the subsequent annual meeting of the Registrant's stockholders, in each case, subject to the Reporting Holder's continued service to the Registrant."}],"balance_after":31250,"derivative":{"exercise_price":14.98,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":31250},"source":{"system":"sec-edgar","filing":"0001209191-22-035066","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919122035066/doc4.xml","form_type":"4"}},{"id":2265822,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-18T20:09:19.000Z","date":"2022-05-16","kind":"exercise","acquired":false,"shares":3195,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest with respect to 1/8th of the underlying shares on May 16, 2022; thereafter, 1/8th of the underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on February 16, 2024, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest with respect to 1/8th of the underlying shares on May 16, 2022; thereafter, 1/8th of the underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on February 16, 2024, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date."}],"balance_after":22371,"derivative":{"underlying":"Common Stock","underlying_shares":3195},"source":{"system":"sec-edgar","filing":"0000899243-22-018595","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924322018595/doc4.xml","form_type":"4"}},{"id":2265821,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-18T20:09:19.000Z","date":"2022-05-16","kind":"tax_withholding","acquired":false,"shares":1310,"price":6.74,"value":8829.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 3,195 shares of Common Stock underlying the Reporting Person's RSUs."}],"balance_after":47745,"source":{"system":"sec-edgar","filing":"0000899243-22-018595","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924322018595/doc4.xml","form_type":"4"}},{"id":2265820,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-18T20:09:19.000Z","date":"2022-05-16","kind":"exercise","acquired":true,"shares":3195,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":49055,"source":{"system":"sec-edgar","filing":"0000899243-22-018595","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924322018595/doc4.xml","form_type":"4"}},{"id":2333416,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-03-15T21:37:26.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":25566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest with respect to 1/8th of the underlying shares on May 16, 2022; thereafter, 1/8th of the underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on February 16, 2024, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest with respect to 1/8th of the underlying shares on May 16, 2022; thereafter, 1/8th of the underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on February 16, 2024, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date."}],"balance_after":25566,"derivative":{"underlying":"Common Stock","underlying_shares":25566},"source":{"system":"sec-edgar","filing":"0000899243-22-011088","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924322011088/doc4.xml","form_type":"4"}},{"id":2483829,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-12-07T01:55:46.000Z","date":"2021-12-02","kind":"grant","acquired":true,"shares":16685,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the underlying shares on December 2, 2022 and thereafter in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date."}],"balance_after":16685,"derivative":{"exercise_price":40.03,"expiration_date":"2031-12-01","underlying":"Common Stock","underlying_shares":16685},"source":{"system":"sec-edgar","filing":"0000899243-21-047030","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924321047030/doc4.xml","form_type":"4"}},{"id":2483828,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-12-07T01:55:46.000Z","date":"2021-12-02","kind":"grant","acquired":true,"shares":28881,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":28881,"derivative":{"exercise_price":40.03,"exercise_date":"2022-12-02","expiration_date":"2031-12-01","underlying":"Common Stock","underlying_shares":28881},"source":{"system":"sec-edgar","filing":"0000899243-21-047030","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924321047030/doc4.xml","form_type":"4"}},{"id":2567457,"issuer":{"id":110693,"kind":"organization","name":"DICE Therapeutics, Inc.","symbol":"DICE"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-09-17T01:26:28.000Z","date":"2021-09-14","kind":"grant","acquired":true,"shares":5600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests as to 1/48th of the total shares monthly, beginning August 20, 2021, subject to the Reporting Holder's continued service to the Registrant."}],"balance_after":5600,"derivative":{"exercise_price":17,"expiration_date":"2031-09-14","underlying":"Common Stock","underlying_shares":5600},"source":{"system":"sec-edgar","filing":"0001209191-21-056524","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919121056524/doc4.xml","form_type":"4"}},{"id":2567456,"issuer":{"id":110693,"kind":"organization","name":"DICE Therapeutics, Inc.","symbol":"DICE"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-09-17T01:26:28.000Z","date":"2021-09-14","kind":"grant","acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests as to 1/48th of the total shares monthly, beginning August 20, 2021, subject to the Reporting Holder's continued service to the Registrant."}],"balance_after":8500,"derivative":{"exercise_price":17,"expiration_date":"2031-09-14","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001209191-21-056524","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919121056524/doc4.xml","form_type":"4"}},{"id":2567455,"issuer":{"id":110693,"kind":"organization","name":"DICE Therapeutics, Inc.","symbol":"DICE"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-09-17T01:26:28.000Z","date":"2021-09-14","kind":"grant","acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests as to 1/48th of the total shares monthly, beginning August 20, 2021, subject to the Reporting Holder's continued service to the Registrant."}],"balance_after":8500,"derivative":{"exercise_price":17,"expiration_date":"2031-09-14","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001209191-21-056524","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919121056524/doc4.xml","form_type":"4"}},{"id":2567454,"issuer":{"id":110693,"kind":"organization","name":"DICE Therapeutics, Inc.","symbol":"DICE"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-09-17T01:26:28.000Z","date":"2021-09-14","kind":"grant","acquired":true,"shares":8261,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests as to 1/36th of the total shares monthly, beginning January 1, 2021, subject to the Reporting Holder's continued service to the Registrant."}],"balance_after":8261,"derivative":{"exercise_price":17,"expiration_date":"2031-09-14","underlying":"Common Stock","underlying_shares":8261},"source":{"system":"sec-edgar","filing":"0001209191-21-056524","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919121056524/doc4.xml","form_type":"4"}},{"id":2567453,"issuer":{"id":110693,"kind":"organization","name":"DICE Therapeutics, Inc.","symbol":"DICE"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-09-17T01:26:28.000Z","date":"2021-09-14","kind":"grant","acquired":true,"shares":9138,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests as to 1/48th of the total shares monthly, beginning October 2, 2018, subject to the Reporting Holder's continued service to the Registrant."}],"balance_after":9138,"derivative":{"exercise_price":17,"expiration_date":"2031-09-14","underlying":"Common Stock","underlying_shares":9138},"source":{"system":"sec-edgar","filing":"0001209191-21-056524","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919121056524/doc4.xml","form_type":"4"}},{"id":2567452,"issuer":{"id":110693,"kind":"organization","name":"DICE Therapeutics, Inc.","symbol":"DICE"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-09-17T01:26:28.000Z","date":"2021-09-14","kind":"grant","acquired":true,"shares":4357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":4357,"derivative":{"exercise_price":17,"expiration_date":"2031-09-14","underlying":"Common Stock","underlying_shares":4357},"source":{"system":"sec-edgar","filing":"0001209191-21-056524","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919121056524/doc4.xml","form_type":"4"}},{"id":2568427,"issuer":{"id":76268,"kind":"organization","name":"Chrome Holding Co.","symbol":"MEHCQ"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock, $0.0001 par value","published_at":"2021-09-16T16:24:30.000Z","date":"2021-09-14","kind":"grant","acquired":true,"shares":18421,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares are represented by restricted stock units, or RSUs, all of which shall vest in full on the earlier of (a) the first anniversary of the grant date or (b) the date of the issuer's 2022 annual meeting of stockholders. Each RSU represents the contingent right to receive one share of Class A common stock of the issuer."}],"balance_after":18421,"source":{"system":"sec-edgar","filing":"0001209191-21-056395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804591/000120919121056395/doc4.xml","form_type":"4"}},{"id":2609863,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-08-09T22:13:39.000Z","date":"2021-08-05","kind":"exercise","acquired":false,"shares":56260,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vest in 48 equal monthly installments beginning on November 22, 2018."}],"balance_after":25574,"derivative":{"exercise_price":10.14,"expiration_date":"2028-11-05","underlying":"Common Stock","underlying_shares":56260},"source":{"system":"sec-edgar","filing":"0001209191-21-050471","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919121050471/doc4.xml","form_type":"4"}},{"id":2609862,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-09T22:13:39.000Z","date":"2021-08-05","kind":"sale","acquired":false,"shares":3392,"price":28.3022,"value":96001.0624,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.23 to $28.48, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-050471","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919121050471/doc4.xml","form_type":"4"}},{"id":2609861,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-09T22:13:39.000Z","date":"2021-08-05","kind":"sale","acquired":false,"shares":52868,"price":27.6413,"value":1461340.2484,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $27.17 to $27.94 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":3392,"source":{"system":"sec-edgar","filing":"0001209191-21-050471","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919121050471/doc4.xml","form_type":"4"}},{"id":2609860,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-09T22:13:39.000Z","date":"2021-08-05","kind":"exercise","acquired":true,"shares":56260,"price":10.14,"value":570476.4,"ownership":{"direct":true},"balance_after":56260,"source":{"system":"sec-edgar","filing":"0001209191-21-050471","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919121050471/doc4.xml","form_type":"4"}},{"id":2609859,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-09T22:13:39.000Z","date":"2021-07-02","kind":"sale","acquired":false,"shares":9981,"price":31.14,"value":310808.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-050471","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919121050471/doc4.xml","form_type":"4"}},{"id":2611595,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-06T22:08:27.000Z","date":"2021-08-04","kind":"exercise","acquired":false,"shares":13777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest and become exercisable in 48 equal monthly installments after June 26, 2019, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":39611,"derivative":{"exercise_price":17,"expiration_date":"2029-06-26","underlying":"Common Stock","underlying_shares":13777},"source":{"system":"sec-edgar","filing":"0000899243-21-031954","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924321031954/doc4.xml","form_type":"4"}},{"id":2611594,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-08-06T22:08:27.000Z","date":"2021-08-04","kind":"sale","acquired":false,"shares":13777,"price":53.2276,"value":733316.6452,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price of the shares sold from $52.839 to $53.68 per share.  The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions as reported in this footnote."}],"balance_after":45860,"source":{"system":"sec-edgar","filing":"0000899243-21-031954","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924321031954/doc4.xml","form_type":"4"}},{"id":2611593,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-08-06T22:08:27.000Z","date":"2021-08-04","kind":"exercise","acquired":true,"shares":13777,"price":17,"value":234209.0,"ownership":{"direct":true},"balance_after":59637,"source":{"system":"sec-edgar","filing":"0000899243-21-031954","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924321031954/doc4.xml","form_type":"4"}},{"id":2658954,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of R&D"}}],"security":"Stock Option (right to buy)","published_at":"2021-06-22T22:51:19.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":38895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in three annual installments after June 17, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date."}],"balance_after":38895,"derivative":{"exercise_price":62.63,"expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":38895},"source":{"system":"sec-edgar","filing":"0000899243-21-025367","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924321025367/doc4.xml","form_type":"4"}},{"id":2658559,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-22T21:05:38.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":25709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 12 equal monthly installments beginning on July 17, 2021 and vest in full on the earlier of the date of the Issuer's next annual meeting of stockholders or June 17, 2022."}],"balance_after":25709,"derivative":{"exercise_price":21.37,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":25709},"source":{"system":"sec-edgar","filing":"0001209191-21-042431","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919121042431/doc4.xml","form_type":"4"}},{"id":2698492,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-24T23:29:24.000Z","date":"2021-05-24","kind":"sale","acquired":false,"shares":100,"price":25,"value":2500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":39092,"source":{"system":"sec-edgar","filing":"0001209191-21-035524","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919121035524/doc4.xml","form_type":"4"}},{"id":2698491,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-24T23:29:24.000Z","date":"2021-05-21","kind":"sale","acquired":false,"shares":1231,"price":25.1895,"value":31008.2745,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 1,231 shares sold in the price range of $25.00 to $25.35 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":39192,"source":{"system":"sec-edgar","filing":"0001209191-21-035524","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919121035524/doc4.xml","form_type":"4"}},{"id":2698490,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-24T23:29:24.000Z","date":"2021-05-20","kind":"sale","acquired":false,"shares":659,"price":25.0805,"value":16528.0495,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 659 shares sold in the price range of $25.00 to $25.15 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":40423,"source":{"system":"sec-edgar","filing":"0001209191-21-035524","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919121035524/doc4.xml","form_type":"4"}},{"id":2707526,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-19T00:20:01.000Z","date":"2021-05-18","kind":"sale","acquired":false,"shares":2800,"price":25.3422,"value":70958.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average share price of an aggregate total of 2,800 shares sold in the price range of $25.00 to $25.68 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":41082,"source":{"system":"sec-edgar","filing":"0001209191-21-033815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919121033815/doc4.xml","form_type":"4"}},{"id":2707525,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-19T00:20:01.000Z","date":"2021-05-17","kind":"sale","acquired":false,"shares":500,"price":25.0602,"value":12530.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 500 shares sold in the price range of $25.00 to $25.12 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":43882,"source":{"system":"sec-edgar","filing":"0001209191-21-033815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919121033815/doc4.xml","form_type":"4"}},{"id":2707524,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-19T00:20:01.000Z","date":"2021-05-14","kind":"sale","acquired":false,"shares":4615,"price":25.3774,"value":117116.701,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 4,615 shares sold in the price range of $25.00 to $25.84 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":44382,"source":{"system":"sec-edgar","filing":"0001209191-21-033815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919121033815/doc4.xml","form_type":"4"}},{"id":2714174,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-13T23:59:07.000Z","date":"2021-05-13","kind":"sale","acquired":false,"shares":100,"price":25,"value":2500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":48997,"source":{"system":"sec-edgar","filing":"0001209191-21-032509","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919121032509/doc4.xml","form_type":"4"}},{"id":2714173,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-13T23:59:07.000Z","date":"2021-05-12","kind":"sale","acquired":false,"shares":103,"price":25.0038,"value":2575.3914,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 103 shares sold in the price range of $25.00 to $25.13 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":49097,"source":{"system":"sec-edgar","filing":"0001209191-21-032509","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919121032509/doc4.xml","form_type":"4"}},{"id":2714172,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-13T23:59:07.000Z","date":"2021-05-11","kind":"sale","acquired":false,"shares":300,"price":25.1596,"value":7547.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 300 shares sold in the price range of $25.09 to $25.27 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":49200,"source":{"system":"sec-edgar","filing":"0001209191-21-032509","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919121032509/doc4.xml","form_type":"4"}},{"id":2734355,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-30T23:57:37.000Z","date":"2021-04-30","kind":"sale","acquired":false,"shares":100,"price":25.19,"value":2519.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":49500,"source":{"system":"sec-edgar","filing":"0001209191-21-029378","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919121029378/doc4.xml","form_type":"4"}},{"id":2734354,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-30T23:57:37.000Z","date":"2021-04-28","kind":"sale","acquired":false,"shares":200,"price":25.11,"value":5022.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":49600,"source":{"system":"sec-edgar","filing":"0001209191-21-029378","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919121029378/doc4.xml","form_type":"4"}},{"id":2757254,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-05T23:45:22.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":200,"price":25,"value":5000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":49800,"source":{"system":"sec-edgar","filing":"0001209191-21-025495","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919121025495/doc4.xml","form_type":"4"}},{"id":2933154,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-12-23T22:35:45.000Z","date":"2020-12-21","kind":"sale","acquired":false,"shares":45473,"price":65.4828,"value":2977699.3644,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold from $65.15 to $65.76 per share."}],"balance_after":45860,"source":{"system":"sec-edgar","filing":"0000899243-20-035011","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924320035011/doc4.xml","form_type":"4"}},{"id":2933153,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-12-23T22:35:45.000Z","date":"2020-12-21","kind":"sale","acquired":false,"shares":14928,"price":64.8069,"value":967437.4032,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price of the shares sold from $64.15 to $65.13 per share.  The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions as reported in footnotes 1 and 2."}],"balance_after":91333,"source":{"system":"sec-edgar","filing":"0000899243-20-035011","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924320035011/doc4.xml","form_type":"4"}},{"id":2936334,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-12-21T21:05:07.000Z","date":"2020-12-18","kind":"sale","acquired":false,"shares":2895,"price":65.7795,"value":190431.6525,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold from $65.685 to $65.95 per share."}],"balance_after":106261,"source":{"system":"sec-edgar","filing":"0000899243-20-034688","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924320034688/doc4.xml","form_type":"4"}},{"id":2936333,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-12-21T21:05:07.000Z","date":"2020-12-18","kind":"sale","acquired":false,"shares":27105,"price":64.9913,"value":1761589.1865,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price of the shares sold from $64.67 to $65.65 per share.  The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a securuity holder of the Issuer, full information regarding the number of share sold at each separate price for all transactions as reported in footnotes 1 and 2."}],"balance_after":109156,"source":{"system":"sec-edgar","filing":"0000899243-20-034688","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924320034688/doc4.xml","form_type":"4"}},{"id":2940357,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-17T21:05:07.000Z","date":"2020-12-15","kind":"exercise","acquired":false,"shares":29277,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option vest and become exercisable in 48 equal monthly installments after June 26, 2019, subject to the Reporting Person's continued service to the Issuer through each\nsuch date."}],"balance_after":53388,"derivative":{"exercise_price":17,"expiration_date":"2029-06-26","underlying":"Common Stock","underlying_shares":29277},"source":{"system":"sec-edgar","filing":"0000899243-20-034280","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924320034280/doc4.xml","form_type":"4"}},{"id":2940356,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-12-17T21:05:07.000Z","date":"2020-12-15","kind":"sale","acquired":false,"shares":19352,"price":60.7329,"value":1175303.0808,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold from $60.40 to $61.17 per share"}],"balance_after":136261,"source":{"system":"sec-edgar","filing":"0000899243-20-034280","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924320034280/doc4.xml","form_type":"4"}},{"id":2940355,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-12-17T21:05:07.000Z","date":"2020-12-15","kind":"sale","acquired":false,"shares":12091,"price":59.806,"value":723114.346,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price of the shares sold from $59.40 to $60.39 per share.  The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a securuity holder of the Issuer, full information regarding the number of share sold at each separate price for all transactions as reported in footnotes 1 and 2."}],"balance_after":155613,"source":{"system":"sec-edgar","filing":"0000899243-20-034280","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924320034280/doc4.xml","form_type":"4"}},{"id":2940354,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-12-17T21:05:07.000Z","date":"2020-12-15","kind":"exercise","acquired":true,"shares":29277,"price":17,"value":497709.0,"ownership":{"direct":true},"balance_after":167704,"source":{"system":"sec-edgar","filing":"0000899243-20-034280","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924320034280/doc4.xml","form_type":"4"}},{"id":3027094,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-09-18T20:05:20.000Z","date":"2020-09-16","kind":"sale","acquired":false,"shares":25000,"price":37.5,"value":937500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 21, 2020."}],"balance_after":138427,"source":{"system":"sec-edgar","filing":"0000899243-20-025693","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924320025693/doc4.xml","form_type":"4"}},{"id":3122270,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-06-04T23:17:15.000Z","date":"2020-06-02","kind":"grant","acquired":true,"shares":112422,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in three annual installments after June 2, 2020, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date."}],"balance_after":112422,"derivative":{"exercise_price":29,"expiration_date":"2030-06-01","underlying":"Common Stock","underlying_shares":112422},"source":{"system":"sec-edgar","filing":"0000899243-20-015301","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924320015301/doc4.xml","form_type":"4"}},{"id":3150449,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-13T23:21:54.000Z","date":"2020-05-11","kind":"grant","acquired":true,"shares":19274,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 12 equal monthly installments beginning on June 11, 2020  and vest in full on the earlier of the date of the Issuer's next annual meeting of stockholders or May 11, 2021."}],"balance_after":19274,"derivative":{"exercise_price":29.09,"expiration_date":"2030-05-11","underlying":"Common Stock","underlying_shares":19274},"source":{"system":"sec-edgar","filing":"0001209191-20-028995","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919120028995/doc4.xml","form_type":"4"}},{"id":3168220,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-04-28T21:09:40.000Z","date":"2020-04-28","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-20-025985","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919120025985/doc4.xml","form_type":"4"}},{"id":3168219,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-28T21:09:40.000Z","date":"2020-04-28","kind":"exercise","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001209191-20-025985","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919120025985/doc4.xml","form_type":"4"}},{"id":3168962,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-04-27T20:40:04.000Z","date":"2020-04-23","kind":"grant","acquired":true,"shares":33250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One thirty-sixth (1/36) of the shares subject to the option shall vest May 23, 2020, and an additional thirty-sixth (1/36) of the shares subject to the option shall vest each month thereafter."}],"balance_after":33250,"derivative":{"exercise_price":16,"expiration_date":"2030-04-22","underlying":"Common Stock","underlying_shares":33250},"source":{"system":"sec-edgar","filing":"0001209191-20-025805","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919120025805/doc4.xml","form_type":"4"}},{"id":3286316,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-06T22:19:53.000Z","date":"2020-02-04","kind":"sale","acquired":false,"shares":10000,"price":29.67,"value":296700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $29.50 to $29.88 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":9981,"source":{"system":"sec-edgar","filing":"0001209191-20-007210","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919120007210/doc4.xml","form_type":"4"}},{"id":3301162,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-01-27T23:40:20.000Z","date":"2020-01-01","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One forty-eighth (1/48th) of the shares subject to the option shall vest on January 6, 2020, and an additional one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter, provided the Reporting Person continues to serve as a consultant under the terms of the consulting agreement between the Reporting Person and the Issuer."}],"balance_after":100000,"derivative":{"exercise_price":17.23,"expiration_date":"2029-12-31","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-20-005056","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919120005056/doc4.xml","form_type":"4"}},{"id":3341115,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2019-12-17T02:07:55.000Z","date":"2019-12-12","kind":"grant","acquired":true,"shares":82878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in three annual installments after December 12, 2019, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":82878,"derivative":{"exercise_price":37.45,"expiration_date":"2029-12-11","underlying":"Common Stock","underlying_shares":82878},"source":{"system":"sec-edgar","filing":"0000899243-19-029358","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924319029358/doc4.xml","form_type":"4"}},{"id":3410607,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-18T23:39:09.000Z","date":"2019-09-16","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the three year anniversary of the grant date."}],"balance_after":15000,"derivative":{"exercise_price":9.44,"expiration_date":"2029-09-15","underlying":"Common Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-19-050164","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1214133/000120919119050164/doc4.xml","form_type":"4"}},{"id":3468306,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Management Incentive Units","published_at":"2019-07-03T20:17:17.000Z","date":"2019-07-01","kind":"exercise","acquired":false,"shares":35742,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), all units in BridgeBio Pharma LLC (the \"LLC\") held by the Reporting Person were exchanged for shares of Common Stock, par value $0.001 per share (the \"Common Stock\"), of the Issuer in an exempt transaction pursuant to Rules 16b-3, 16b-6 and 16b-7 (the \"Reorganization\").  In connection with the Reorganization, a wholly-owned subsidiary of the Issuer was merged with and into the LLC, and shares of Common Stock were allocated to the holders of outstanding units in the LLC pursuant to the distribution provisions of the Fourth Amended and Restated Limited Liability Company Agreement of the LLC, dated November 20, 2018, as amended, based upon the liquidation value of the LLC, assuming it was liquidated immediately prior to the closing of the IPO with a value implied by the IPO price of $17.00 per share.  The LLC units have no expiration date."},{"field":"shares","element":"transactionShares","label":"F6","text":"Represents shares of restricted Common Stock issuable in the Reorganization in exchange for Management Incentive Units in the LLC held by the Reporting Person.  The shares are subject to vesting at a rate of 1/60 per month from a vesting commencement date of February 12, 2019, such that the shares shall be fully vested on February 12, 2024, subject to the Reporting Person's continued service relationship to the Issuer through each vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), all units in BridgeBio Pharma LLC (the \"LLC\") held by the Reporting Person were exchanged for shares of Common Stock, par value $0.001 per share (the \"Common Stock\"), of the Issuer in an exempt transaction pursuant to Rules 16b-3, 16b-6 and 16b-7 (the \"Reorganization\").  In connection with the Reorganization, a wholly-owned subsidiary of the Issuer was merged with and into the LLC, and shares of Common Stock were allocated to the holders of outstanding units in the LLC pursuant to the distribution provisions of the Fourth Amended and Restated Limited Liability Company Agreement of the LLC, dated November 20, 2018, as amended, based upon the liquidation value of the LLC, assuming it was liquidated immediately prior to the closing of the IPO with a value implied by the IPO price of $17.00 per share.  The LLC units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), all units in BridgeBio Pharma LLC (the \"LLC\") held by the Reporting Person were exchanged for shares of Common Stock, par value $0.001 per share (the \"Common Stock\"), of the Issuer in an exempt transaction pursuant to Rules 16b-3, 16b-6 and 16b-7 (the \"Reorganization\").  In connection with the Reorganization, a wholly-owned subsidiary of the Issuer was merged with and into the LLC, and shares of Common Stock were allocated to the holders of outstanding units in the LLC pursuant to the distribution provisions of the Fourth Amended and Restated Limited Liability Company Agreement of the LLC, dated November 20, 2018, as amended, based upon the liquidation value of the LLC, assuming it was liquidated immediately prior to the closing of the IPO with a value implied by the IPO price of $17.00 per share.  The LLC units have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":35742},"source":{"system":"sec-edgar","filing":"0000899243-19-019151","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924319019151/doc4.xml","form_type":"4"}},{"id":3468305,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Management Incentive Units","published_at":"2019-07-03T20:17:17.000Z","date":"2019-07-01","kind":"exercise","acquired":false,"shares":42100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), all units in BridgeBio Pharma LLC (the \"LLC\") held by the Reporting Person were exchanged for shares of Common Stock, par value $0.001 per share (the \"Common Stock\"), of the Issuer in an exempt transaction pursuant to Rules 16b-3, 16b-6 and 16b-7 (the \"Reorganization\").  In connection with the Reorganization, a wholly-owned subsidiary of the Issuer was merged with and into the LLC, and shares of Common Stock were allocated to the holders of outstanding units in the LLC pursuant to the distribution provisions of the Fourth Amended and Restated Limited Liability Company Agreement of the LLC, dated November 20, 2018, as amended, based upon the liquidation value of the LLC, assuming it was liquidated immediately prior to the closing of the IPO with a value implied by the IPO price of $17.00 per share.  The LLC units have no expiration date."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares of restricted Common Stock issuable in the Reorganization in exchange for Management Incentive Units in the LLC held by the Reporting Person.  The shares are subject to vesting at a rate of 1/60 per month from a vesting commencement date of January 19, 2018, such that the shares shall be fully vested on January 19, 2023, subject to the Reporting Person's continued service relationship to the Issuer through each vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), all units in BridgeBio Pharma LLC (the \"LLC\") held by the Reporting Person were exchanged for shares of Common Stock, par value $0.001 per share (the \"Common Stock\"), of the Issuer in an exempt transaction pursuant to Rules 16b-3, 16b-6 and 16b-7 (the \"Reorganization\").  In connection with the Reorganization, a wholly-owned subsidiary of the Issuer was merged with and into the LLC, and shares of Common Stock were allocated to the holders of outstanding units in the LLC pursuant to the distribution provisions of the Fourth Amended and Restated Limited Liability Company Agreement of the LLC, dated November 20, 2018, as amended, based upon the liquidation value of the LLC, assuming it was liquidated immediately prior to the closing of the IPO with a value implied by the IPO price of $17.00 per share.  The LLC units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), all units in BridgeBio Pharma LLC (the \"LLC\") held by the Reporting Person were exchanged for shares of Common Stock, par value $0.001 per share (the \"Common Stock\"), of the Issuer in an exempt transaction pursuant to Rules 16b-3, 16b-6 and 16b-7 (the \"Reorganization\").  In connection with the Reorganization, a wholly-owned subsidiary of the Issuer was merged with and into the LLC, and shares of Common Stock were allocated to the holders of outstanding units in the LLC pursuant to the distribution provisions of the Fourth Amended and Restated Limited Liability Company Agreement of the LLC, dated November 20, 2018, as amended, based upon the liquidation value of the LLC, assuming it was liquidated immediately prior to the closing of the IPO with a value implied by the IPO price of $17.00 per share.  The LLC units have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":42100},"source":{"system":"sec-edgar","filing":"0000899243-19-019151","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924319019151/doc4.xml","form_type":"4"}},{"id":3468304,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Management Incentive Units","published_at":"2019-07-03T20:17:17.000Z","date":"2019-07-01","kind":"exercise","acquired":false,"shares":59381,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), all units in BridgeBio Pharma LLC (the \"LLC\") held by the Reporting Person were exchanged for shares of Common Stock, par value $0.001 per share (the \"Common Stock\"), of the Issuer in an exempt transaction pursuant to Rules 16b-3, 16b-6 and 16b-7 (the \"Reorganization\").  In connection with the Reorganization, a wholly-owned subsidiary of the Issuer was merged with and into the LLC, and shares of Common Stock were allocated to the holders of outstanding units in the LLC pursuant to the distribution provisions of the Fourth Amended and Restated Limited Liability Company Agreement of the LLC, dated November 20, 2018, as amended, based upon the liquidation value of the LLC, assuming it was liquidated immediately prior to the closing of the IPO with a value implied by the IPO price of $17.00 per share.  The LLC units have no expiration date."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of restricted Common Stock issuable in the Reorganization in exchange for Management Incentive Units in the LLC held by the Reporting Person.  The shares are subject to vesting at a rate of 1/60 per month from a vesting commencement date of March 26, 2016, such that the shares shall be fully vested on March 26, 2021, subject to the Reporting Person's continued service relationship to the Issuer through each vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), all units in BridgeBio Pharma LLC (the \"LLC\") held by the Reporting Person were exchanged for shares of Common Stock, par value $0.001 per share (the \"Common Stock\"), of the Issuer in an exempt transaction pursuant to Rules 16b-3, 16b-6 and 16b-7 (the \"Reorganization\").  In connection with the Reorganization, a wholly-owned subsidiary of the Issuer was merged with and into the LLC, and shares of Common Stock were allocated to the holders of outstanding units in the LLC pursuant to the distribution provisions of the Fourth Amended and Restated Limited Liability Company Agreement of the LLC, dated November 20, 2018, as amended, based upon the liquidation value of the LLC, assuming it was liquidated immediately prior to the closing of the IPO with a value implied by the IPO price of $17.00 per share.  The LLC units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), all units in BridgeBio Pharma LLC (the \"LLC\") held by the Reporting Person were exchanged for shares of Common Stock, par value $0.001 per share (the \"Common Stock\"), of the Issuer in an exempt transaction pursuant to Rules 16b-3, 16b-6 and 16b-7 (the \"Reorganization\").  In connection with the Reorganization, a wholly-owned subsidiary of the Issuer was merged with and into the LLC, and shares of Common Stock were allocated to the holders of outstanding units in the LLC pursuant to the distribution provisions of the Fourth Amended and Restated Limited Liability Company Agreement of the LLC, dated November 20, 2018, as amended, based upon the liquidation value of the LLC, assuming it was liquidated immediately prior to the closing of the IPO with a value implied by the IPO price of $17.00 per share.  The LLC units have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":59381},"source":{"system":"sec-edgar","filing":"0000899243-19-019151","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924319019151/doc4.xml","form_type":"4"}},{"id":3468303,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Units","published_at":"2019-07-03T20:17:17.000Z","date":"2019-07-01","kind":"exercise","acquired":false,"shares":19318,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), all units in BridgeBio Pharma LLC (the \"LLC\") held by the Reporting Person were exchanged for shares of Common Stock, par value $0.001 per share (the \"Common Stock\"), of the Issuer in an exempt transaction pursuant to Rules 16b-3, 16b-6 and 16b-7 (the \"Reorganization\").  In connection with the Reorganization, a wholly-owned subsidiary of the Issuer was merged with and into the LLC, and shares of Common Stock were allocated to the holders of outstanding units in the LLC pursuant to the distribution provisions of the Fourth Amended and Restated Limited Liability Company Agreement of the LLC, dated November 20, 2018, as amended, based upon the liquidation value of the LLC, assuming it was liquidated immediately prior to the closing of the IPO with a value implied by the IPO price of $17.00 per share.  The LLC units have no expiration date."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of restricted Common Stock issuable in the Reorganization in exchange for Common Units in the LLC held by the Reporting Person. The shares are subject to vesting at a rate of 1/60 per month from a vesting commencement date of May 6, 2015, such that the shares shall be fully vested on May 6, 2020, subject to the Reporting Person's continued service relationship to the Issuer through each vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), all units in BridgeBio Pharma LLC (the \"LLC\") held by the Reporting Person were exchanged for shares of Common Stock, par value $0.001 per share (the \"Common Stock\"), of the Issuer in an exempt transaction pursuant to Rules 16b-3, 16b-6 and 16b-7 (the \"Reorganization\").  In connection with the Reorganization, a wholly-owned subsidiary of the Issuer was merged with and into the LLC, and shares of Common Stock were allocated to the holders of outstanding units in the LLC pursuant to the distribution provisions of the Fourth Amended and Restated Limited Liability Company Agreement of the LLC, dated November 20, 2018, as amended, based upon the liquidation value of the LLC, assuming it was liquidated immediately prior to the closing of the IPO with a value implied by the IPO price of $17.00 per share.  The LLC units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), all units in BridgeBio Pharma LLC (the \"LLC\") held by the Reporting Person were exchanged for shares of Common Stock, par value $0.001 per share (the \"Common Stock\"), of the Issuer in an exempt transaction pursuant to Rules 16b-3, 16b-6 and 16b-7 (the \"Reorganization\").  In connection with the Reorganization, a wholly-owned subsidiary of the Issuer was merged with and into the LLC, and shares of Common Stock were allocated to the holders of outstanding units in the LLC pursuant to the distribution provisions of the Fourth Amended and Restated Limited Liability Company Agreement of the LLC, dated November 20, 2018, as amended, based upon the liquidation value of the LLC, assuming it was liquidated immediately prior to the closing of the IPO with a value implied by the IPO price of $17.00 per share.  The LLC units have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":19318},"source":{"system":"sec-edgar","filing":"0000899243-19-019151","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924319019151/doc4.xml","form_type":"4"}},{"id":3468302,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Units","published_at":"2019-07-03T20:17:17.000Z","date":"2019-07-01","kind":"exercise","acquired":false,"shares":6886,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), all units in BridgeBio Pharma LLC (the \"LLC\") held by the Reporting Person were exchanged for shares of Common Stock, par value $0.001 per share (the \"Common Stock\"), of the Issuer in an exempt transaction pursuant to Rules 16b-3, 16b-6 and 16b-7 (the \"Reorganization\").  In connection with the Reorganization, a wholly-owned subsidiary of the Issuer was merged with and into the LLC, and shares of Common Stock were allocated to the holders of outstanding units in the LLC pursuant to the distribution provisions of the Fourth Amended and Restated Limited Liability Company Agreement of the LLC, dated November 20, 2018, as amended, based upon the liquidation value of the LLC, assuming it was liquidated immediately prior to the closing of the IPO with a value implied by the IPO price of $17.00 per share.  The LLC units have no expiration date."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Common Stock issuable in the Reorganization in exchange for Common Units in the LLC held by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), all units in BridgeBio Pharma LLC (the \"LLC\") held by the Reporting Person were exchanged for shares of Common Stock, par value $0.001 per share (the \"Common Stock\"), of the Issuer in an exempt transaction pursuant to Rules 16b-3, 16b-6 and 16b-7 (the \"Reorganization\").  In connection with the Reorganization, a wholly-owned subsidiary of the Issuer was merged with and into the LLC, and shares of Common Stock were allocated to the holders of outstanding units in the LLC pursuant to the distribution provisions of the Fourth Amended and Restated Limited Liability Company Agreement of the LLC, dated November 20, 2018, as amended, based upon the liquidation value of the LLC, assuming it was liquidated immediately prior to the closing of the IPO with a value implied by the IPO price of $17.00 per share.  The LLC units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), all units in BridgeBio Pharma LLC (the \"LLC\") held by the Reporting Person were exchanged for shares of Common Stock, par value $0.001 per share (the \"Common Stock\"), of the Issuer in an exempt transaction pursuant to Rules 16b-3, 16b-6 and 16b-7 (the \"Reorganization\").  In connection with the Reorganization, a wholly-owned subsidiary of the Issuer was merged with and into the LLC, and shares of Common Stock were allocated to the holders of outstanding units in the LLC pursuant to the distribution provisions of the Fourth Amended and Restated Limited Liability Company Agreement of the LLC, dated November 20, 2018, as amended, based upon the liquidation value of the LLC, assuming it was liquidated immediately prior to the closing of the IPO with a value implied by the IPO price of $17.00 per share.  The LLC units have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6886},"source":{"system":"sec-edgar","filing":"0000899243-19-019151","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924319019151/doc4.xml","form_type":"4"}},{"id":3468301,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-07-03T20:17:17.000Z","date":"2019-07-01","kind":"exercise","acquired":true,"shares":35742,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Represents shares of restricted Common Stock issuable in the Reorganization in exchange for Management Incentive Units in the LLC held by the Reporting Person.  The shares are subject to vesting at a rate of 1/60 per month from a vesting commencement date of February 12, 2019, such that the shares shall be fully vested on February 12, 2024, subject to the Reporting Person's continued service relationship to the Issuer through each vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), all units in BridgeBio Pharma LLC (the \"LLC\") held by the Reporting Person were exchanged for shares of Common Stock, par value $0.001 per share (the \"Common Stock\"), of the Issuer in an exempt transaction pursuant to Rules 16b-3, 16b-6 and 16b-7 (the \"Reorganization\").  In connection with the Reorganization, a wholly-owned subsidiary of the Issuer was merged with and into the LLC, and shares of Common Stock were allocated to the holders of outstanding units in the LLC pursuant to the distribution provisions of the Fourth Amended and Restated Limited Liability Company Agreement of the LLC, dated November 20, 2018, as amended, based upon the liquidation value of the LLC, assuming it was liquidated immediately prior to the closing of the IPO with a value implied by the IPO price of $17.00 per share.  The LLC units have no expiration date."}],"balance_after":163427,"source":{"system":"sec-edgar","filing":"0000899243-19-019151","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924319019151/doc4.xml","form_type":"4"}},{"id":3468300,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":37180,"kind":"person","name":"SCHELLER RICHARD H","position":1,"cik":"0001214133","reported_name":"SCHELLER RICHARD H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-07-03T20:17:17.000Z","date":"2019-07-01","kind":"exercise","acquired":true,"shares":42100,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares of restricted Common Stock issuable in the Reorganization in exchange for Management Incentive Units in the LLC held by the Reporting Person.  The shares are subject to vesting at a rate of 1/60 per month from a vesting commencement date of January 19, 2018, such that the shares shall be fully vested on January 19, 2023, subject to the Reporting Person's continued service relationship to the Issuer through each vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering (the \"IPO\"), all units in BridgeBio Pharma LLC (the \"LLC\") held by the Reporting Person were exchanged for shares of Common Stock, par value $0.001 per share (the \"Common Stock\"), of the Issuer in an exempt transaction pursuant to Rules 16b-3, 16b-6 and 16b-7 (the \"Reorganization\").  In connection with the Reorganization, a wholly-owned subsidiary of the Issuer was merged with and into the LLC, and shares of Common Stock were allocated to the holders of outstanding units in the LLC pursuant to the distribution provisions of the Fourth Amended and Restated Limited Liability Company Agreement of the LLC, dated November 20, 2018, as amended, based upon the liquidation value of the LLC, assuming it was liquidated immediately prior to the closing of the IPO with a value implied by the IPO price of $17.00 per share.  The LLC units have no expiration date."}],"balance_after":127685,"source":{"system":"sec-edgar","filing":"0000899243-19-019151","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924319019151/doc4.xml","form_type":"4"}}],"next_cursor":"2019-07-03T20:17:17.000000Z,3468300"}